Annals of Emergency Medicine
Volume 49, Issue 6 , Pages 772-777 , June 2007

Pneumococcal Bacteremia in Febrile Infants Presenting to the Emergency Department Before and After the Introduction of the Heptavalent Pneumococcal Vaccine

Presented at the Society for Academic Emergency Medicine annual meeting, May 2004, Orlando, FL.

  • Keri L. Carstairs, MD

      Affiliations

    • Department of Emergency Medicine, Naval Medical Center San Diego, San Diego, CA
    • Corresponding Author InformationAddress for correspondence: Keri L. Carstairs, MD, Department of Emergency Medicine, Naval Medical Center San Diego, 34-800 Bob Wilson Drive, San Diego, CA 92134-5000; 619-532-8276, fax 619-532-5307
    • ,
  • David A. Tanen, MD

      Affiliations

    • Department of Emergency Medicine, Naval Medical Center San Diego, San Diego, CA
    • ,
  • Andrew S. Johnson, MD, MPH

      Affiliations

    • Department of Emergency Medicine, Naval Medical Center San Diego, San Diego, CA
    • ,
  • Steven B. Kailes, MD, MPH

      Affiliations

    • Department of Emergency Medicine, Naval Medical Center San Diego, San Diego, CA
    • ,
  • Robert H. Riffenburgh, PhD

      Affiliations

    • Clinical Investigators Department, Naval Medical Center San Diego, San Diego, CA.

Received 12 January 2006 ,Revised 22 September 2006 ,Accepted 31 October 2006.

References 

  1. Slater M, Krug SE. Evaluation of the infant with fever source: an evidence based approach. Emerg Med Clin North Am. 1999;17:97–126
  2. Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med. 1998;152:624–628
  3. American College of Emergency Physicians. ACEP clinical policy for children younger than three years presenting to the emergency department with fever. Ann Emerg Med. 2003;42:530–545
  4. Baraff LJ. Clinical policy for children younger than three years presenting to the emergency department with fever. [editorial] Ann Emerg Med. 2003;42:546–549
  5. Kupperman N. The evaluation of young febrile children for occult bacteremia: time to reevaluate our approach?. Arch Pediatr Adolesc Med. 2002;156:855–857
  6. Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med. 2000;36:602–614
  7. Lee GM, Fleisher GR, Harper MB. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. Pediatrics. 2001;108:835–844
  8. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without a source. Ann Emerg Med. 1993;22:1198–1210
  9. Bass JW, Steele RW, Witler RR, et al. Antimicrobial treatment of occult bacteremia: a multicenter cooperative study. Pediatr Infect Dis. 1993;12:466–473
  10. Levine OS, Fadey M, Harrison LH, et al. Risk factors for invasive disease in children: a population-based case-control study in North America. Pediatrics. 1999;103:E28
  11. Alpern ER, Alessandrini EA, Bell LM, et al. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics. 2000;106:505–511
  12. Black S, Shinefield H, Fireman B, et al. Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187–195
  13. Black SB, Shinefield HR, Hansen J, et al. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2001;20:1105–1107
  14. Herz AM, Greenhow TL, Alcantara J, et al. Changing epidemiology of outpatient bacteremia in the 3-36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis. 2006;25:293–300
  15. Hsaio AL, Chen L, Baker D. Incidence and predictors of serious bacterial infections among 57-180-day-old infants. Pediatrics. 2006;117:1695–1701
  16. Kornberg AE, Jain N, Dannenhoffer R. Evaluation of false positive blood cultures: guidelines for early detection of contaminated cultures in febrile children. Pediatr Emerg Care. 1994;10:20–22
  17. Gilbert EH, Lowenstein SR, Koziol-McLain J, et al. Chart reviews in emergency medicine research: where are the methods?. Ann Emerg Med. 1996;27:305–308
  18. Kayhty H, Ahman H, Eriksson K, et al. Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5, and 12 months of age. Pediatr Infect Dis J. 2005;24:108–114
  19. Nigrovic LE, Malley R. Evaluation of the febrile child 3 to 36 months old in the era of pneumococcal conjugate vaccine: focus on occult bacteremia. Clin Pediatr Emerg Med. 2004;5:13–19
  20. Kyaw MH, Jones IG, Campbell H. Prevention of pneumococcal disease in children: pneumococcal conjugate vaccines: their use globally could have a major impact on public health. Acta Paediatr. 2001;90:473–476
  21. Stoll ML, Rubin LG. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine. Arch Pediatr Adolesc Med. 2004;158:671–675
  22. Dagan R, Givon-Lavi N, Zamir O, et al. Reduction of nasopharyngeal carriage of streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis. 2002;185:927–936

 Supervising editor: David M. Jaffe, MDAuthor contributions: KLC, DAT, and ASJ conceived and designed the study and obtained research approval. KLC and DAT supervised the conduct of the trial and data collection. KLC, DAT, and SBK performed data collection. ASJ and RHR provided statistical advice on study design and analyzed the data. KLC drafted the article, and all authors contributed substantially to its revision. KLC takes responsibility for the paper as a whole.Funding and support: This study was supported by the Clinical Investigations Department of Naval Medical Center San Diego, CA. The study received no outside funding or support.The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the United States government.Publication dates: Available online March 6, 2007.Reprints not available from the authors.

PII: S0196-0644(06)02537-6

doi: 10.1016/j.annemergmed.2006.10.026

Annals of Emergency Medicine
Volume 49, Issue 6 , Pages 772-777 , June 2007

Article Tools

* Image Usage & Resolution